INACTIVE/DISSOLVED
Address
Novo A/S
19 Tuborg Havnevej
2900 Hellerup
Denmark
Website
VCID: 30981
Profile
Corporate information
Official name
Novo A/S
Renamed to
Official name
Novo A/S
Renamed to
Investment activity status
Not investing
Investments
Investment preferences
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Santaris Pharma A/S |
Denmark | 1 Jun 2012 | Venture Initial investment. Round participant. Active |
|
|
Altheos Inc A drug development company focused on next generation intraocular pressure (IOP) lowering agents for glaucoma and ocular hypertension. |
United States | 1 Feb 2012 | Series A Active |
|
|
|
Orphazyme ApS Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases. |
Denmark | 1 Sep 2011 14 Feb 2011 |
Series A Follow-on investment. Round participant. Active |
|
|
|
Delenex Therapeutics AG |
Switzerland | 1 May 2011 | Series A |
|
|
|
High Throughput Genomics Inc |
United States | 1 Feb 2011 | Series D Active |
|
|
|
Symphogen |
Denmark | 1 Feb 2011 1 Jan 2006 |
Series F Follow-on investment. Round participant. Active |
|
|
|
ProteinSimple ProteinSimple's goal is simply to help researchers gain a better understanding of proteins and their role in disease. |
1 Apr 2009 1 Oct 2010 |
Series F |
||
|
|
Tobira Therapeutics Inc Dedicated to the clinical development of antiviral products |
United States | 1 Sep 2010 | Series B |
|
|
|
Cabrellis Pharmaceuticals Corp Development of important therapies for the treatment of cancer |
United States | 7 Aug 2006 | Series A |
|
|
|
Light Sciences Oncology Inc Drug-device cancer therapy |
United States | 1 Dec 2005 | Series A |
|
|
|
Lux Biosciences Inc Clinical stage biotechnology company specializing in the development and commercialization of innovative medications for serious ophthalmic diseases. |
United States | N/A |
||
|
|
Amira Pharmaceuticals Inc A small molecule pharmaceutical company focused on the discovery and early development of compounds. |
United States | N/A |
||
|
|
MediQuest Therapeutics Inc A specialty pharmaceutical company developing topical therapies to treat patients suffering from inflammatory and infectious diseases. |
United States | N/A |
||
|
|
Ophthotech Corp Clinical-stage biotechnology company, engages in developing and commercializing therapies for wet and dry age-related macular degeneration. |
United States | N/A |
||
|
Inogen Inc Developer and manufacturer of homecare products and services for oxygen therapy patients. |
United States | N/A |
||
|
|
Gloucester Pharmaceuticals Inc |
United States | N/A |
||
|
|
Asante Solutions Inc Developing a disposable drug delivery system which initially will be used for insulin delivery for Type I diabetics. |
United States | N/A |